European Tech Funding Surged Past €4B Last Week

These deals reflect continued investor interest in AI infrastructure, AI‑enabled science, and workforce platforms aligned with the AI economy.

Exits and M&A activity

The week also saw more than 10 exits, acquisitions, and strategic transactions across Europe.

Among the notable developments:

• London-founded payments fintech Banked was acquired by an Australian business lender, illustrating ongoing consolidation in the fintech ecosystem.
• Turkish delivery platform Glocalzone was acquired, highlighting continued cross‑border acquisition activity involving startups from emerging European tech markets.

While only a subset of deals were publicly detailed, the volume of transactions indicates sustained strategic activity alongside venture funding.

Industries that attracted the most capital

Three sectors clearly led the European tech investment landscape last week:

• Healthtech — €1.9 billion
• Artificial intelligence — €787.5 million
• Cloud — €676.6 million

Healthtech topped the list largely because of the Isomorphic Labs mega‑round, which combines AI with drug discovery. AI remained the second‑largest category, with multiple infrastructure, chip, and platform startups raising capital. Cloud and infrastructure investments also remained strong as demand grows for the computing backbone supporting AI systems.

Which countries led European funding

Funding activity was highly concentrated geographically, with the UK overwhelmingly leading the market.

• United Kingdom — about €3.7 billion
• France — about €121.1 million
• Türkiye — about €61.1 million

The UK’s dominance was driven by several of the week’s largest deals, including Isomorphic Labs and multiple AI‑related infrastructure and chip startups. France continued to show steady startup investment activity, while Türkiye’s presence among the top funding destinations reflects the country’s growing role in the broader European startup ecosystem.

The bigger picture

Taken together, the week illustrates several ongoing trends in European venture capital:

• AI continues to absorb a large share of investment, especially in infrastructure and research‑driven applications.
• Healthtech remains a magnet for capital, particularly where AI accelerates drug discovery or biotech innovation.
• The UK continues to dominate European funding totals, often driven by a few extremely large rounds.

With multiple megadeals and strong sector concentration, the week highlights how AI‑driven innovation and scientific research are increasingly shaping where venture capital flows in Europe.